Quick answer
How is PT-141 reconstituted and stored in the laboratory? Keep the sealed lyophilized vial refrigerated at 2–8 °C, or at −20 °C when it will not be opened for a long period, and protect it from heat, moisture and light. Let a cold vial warm to room temperature before the stopper is pierced, run the diluent slowly down the glass, and swirl rather than shake until the liquid is clear. Bacteriostatic water suits a vial that will be entered several times; plain sterile water suits a stock that is divided into single-use aliquots straight away. Return solutions to 2–8 °C, freeze aliquots for longer holding, and thaw each one only once. The single tryptophan in the ring is the residue most worth protecting, so light control matters more for this compound than oxidation of sulfur, which it does not contain.
PT-141 (bremelanotide) is a small cyclic peptide, and its handling profile follows directly from its structure: a lactam ring instead of a disulfide, norleucine where a natural melanocortin would carry methionine, one light-sensitive indole, and a free carboxylic acid at the C-terminus. This guide walks through what those features mean at the bench, from the moment a vial arrives to the last aliquot. It contains no volume recipes; the arithmetic for any vial and diluent volume belongs in the reconstitution calculator. The material discussed is for laboratory research use only and is not for human consumption.
What arrives: the lyophilized PT-141 vial
The PT-141 product page lists a single 10 mg size, supplied as lyophilized powder in a sealed clear glass vial, to a purity specification of ≥98% by HPLC, with the molecular formula C50H68N14O10. The stated storage line is to refrigerate at 2–8 °C, hold at −20 °C for the long term, and protect from heat, moisture and light.
A freeze-dried peptide of this size normally presents as a white to off-white cake or a loose, fluffy plug at the bottom of the vial. A cake that has broken into powder, clings to the wall or sits on the stopper has usually just been jostled in transit; that is cosmetic. What deserves a second look is a cake that has shrunk into a glassy, sticky or translucent bead, or one with a distinct yellow cast, because both can indicate moisture ingress or exposure to warmth. The background on why the dry state is so protective is laid out in what lyophilization is.
| Feature | Detail | Handling consequence |
|---|---|---|
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH | Seven residues; the ring is closed through the Asp and Lys side chains |
| Molecular formula | C50H68N14O10 (about 1,025 g/mol) | Needed for any molar conversion; small enough to dissolve quickly |
| Ring closure | Side-chain lactam (amide bond) | No disulfide to scramble or reduce; reducing agents in a buffer are not a concern for the ring |
| Position 1 | Norleucine in place of methionine | No thioether, so no methionine sulfoxide pathway |
| Tryptophan | One | Indole is the main photo-oxidation target; keep vial and solutions dark |
| Histidine | One | Susceptible to metal-catalyzed oxidation; avoid metal spatulas and rusty needles in contact with solution |
| Termini | N-acetyl; free C-terminal carboxylic acid | One ionizable acid group that the amide analog lacks, which shifts net charge |
| Cysteine, asparagine, glutamine | None | No thiol chemistry and no classical deamidation site |
| Supplied form | Lyophilized powder, 10 mg, sealed clear glass vial | Clear glass passes light; box or foil is part of storage |
Before opening anything, compare the lot number on the label with the document in the COA library, where a certificate has been published for that lot, and file a copy with the receiving record. A walkthrough of each line on such a document is in how to read a COA, and the compound-specific analytical questions are covered in PT-141 purity testing.
Chemistry that shapes PT-141 handling
A lactam ring, not a disulfide
Many cyclic peptides are held closed by a cystine bridge, which brings thiol–disulfide exchange, sensitivity to reducing agents and a tendency to form mixed dimers. PT-141 has none of that. Its ring is an amide bond between the side-chain carboxyl of aspartic acid and the side-chain amine of lysine, the design introduced in the cyclic lactam α-melanotropin analogs described by Al-Obeidi and colleagues in 1989. An amide is far less reactive than a disulfide under ordinary laboratory conditions, so the ring itself is not the weak point. It also means the aspartic acid side chain is not a free carboxylate, and the lysine side chain is not a free amine; neither contributes charge.
Norleucine removes the sulfur problem
Natural α-MSH carries methionine at the corresponding position, and methionine thioethers oxidize readily to the sulfoxide in solution. Substituting norleucine, an isosteric side chain with a methylene where the sulfur would be, removes that pathway entirely. Headspace oxygen is therefore a smaller concern for PT-141 than for a methionine-containing peptide, although it is not irrelevant, because of the next two residues.
Tryptophan and histidine
The indole ring of tryptophan absorbs in the near-UV and is the classic site of photo-oxidation in peptides; degradation products of the kynurenine family are yellow, which is why a yellow tint in a once-colorless solution is read as a warning sign. Histidine is the other residue commonly modified by light-driven and metal-catalyzed oxidation. Both arguments point the same way: the clear glass vial should live in its box, solutions should not sit under bench lighting, and trace metal contamination should be avoided.
The free acid terminus
The one structural difference between PT-141 and Melanotan II is the C-terminus: a carboxylic acid here, an amide there (see the PT-141 vs Melanotan II comparison). At neutral pH that carboxylate is ionized, offsetting the positive charge on arginine, so PT-141 carries roughly one fewer net positive charge than its amide relative. The practical reading is modest: both are handled in water, but the two should not be assumed to behave identically on charged surfaces or in chromatographic checks, and they must never be relabelled as interchangeable.
Counterion
Synthetic peptides are isolated as salts, most often acetate or trifluoroacetate. The product page does not state the salt form, so it should be read from the certificate where one is published rather than assumed. The point matters for two reasons. Counterion and residual water are part of the weighed mass, so net peptide content is below the gross fill. And trifluoroacetate has been reported to affect proliferation in some cell-culture systems, which is a reason to run a vehicle control in sensitive in vitro assays.
Solvent choice: the reasoning
PT-141 is a short, polar, charged peptide and dissolves in water without the help of organic co-solvents. The decision is therefore less about getting it into solution and more about what the solution has to survive afterwards. The general method is described in how to reconstitute a lyophilized peptide; the table applies it to this compound.
| Diluent | Fits when | Strength | Limitation |
|---|---|---|---|
| Bacteriostatic water (water with benzyl alcohol preservative) | One vial will be entered repeatedly over days | Preservative suppresses microbial growth between stopper punctures | Benzyl alcohol is an added variable in cell-based assays and needs a matched vehicle control |
| Sterile water | The stock is divided into single-use aliquots and frozen the same day | No additives; simplest background for analytical or cell work | Unpreserved; not suited to a refrigerated multi-entry vial |
| Buffered saline or assay buffer | Final working dilutions made on the day of the experiment | Matches assay pH and ionic strength | Poor choice for stored stock: salts concentrate on freezing and phosphate systems can shift pH |
| Organic co-solvent, then water | Rarely justified for this compound | Rescues poorly soluble hydrophobic peptides | Adds a solvent variable with no solubility need to justify it |
Two points are specific enough to state plainly. First, there is no chemical reason to reach for a rescue solvent: if the cake seems slow to dissolve, time and gentle rolling are the correct response. Second, the amount of diluent sets the concentration and nothing else; the vial still holds the same mass of material. Choosing that amount is an arithmetic exercise tied to the assay design, and the calculator handles it for any vial size.
Reconstitution technique in outline
- Equilibrate. Bring the sealed vial from cold storage to room temperature before piercing it. Opening a cold vial pulls humid room air onto a hygroscopic cake.
- Clean the closure. Wipe the stopper with an alcohol swab and let it dry completely so that alcohol is not carried into the vial.
- Add diluent down the wall. Aim the stream at the glass, not at the cake. A direct jet foams the liquid and can drive undissolved material up under the stopper.
- Let it wet, then swirl. Give the cake a minute to hydrate, then roll or swirl gently. Do not shake or vortex hard; agitation creates air–liquid interface, where peptides accumulate and aggregate.
- Inspect. Hold the vial against a dark and then a light background before it is used or divided.
- Label at once. Concentration, diluent, date and initials go on the vial before it returns to the refrigerator.
Technique for preserved diluent in particular is expanded in bacteriostatic water explained.
Storage tiers for PT-141
The tiers below follow the storage line on the product page for the dry material and general peptide-laboratory convention for solutions. They are handling practice, not validated shelf lives for a specific lot.
| State | Temperature | Role | Notes |
|---|---|---|---|
| Lyophilized, sealed | 2–8 °C | Routine storage | Boxed and dry; the stated default for the supplied vial |
| Lyophilized, sealed | −20 °C | Long-term holding | Use a manual-defrost freezer where possible; warm fully before opening |
| Lyophilized, in transit or on the bench | Ambient | Short excursions only | Move to cold storage on receipt; avoid heat and direct sun |
| Solution in bacteriostatic water | 2–8 °C | Multi-entry working vial | Laboratory convention limits preserved multi-use vials to a few weeks; shorten for sensitive assays |
| Solution in sterile water | 2–8 °C | Same-day or next-day use | No preservative; aliquot and freeze instead of holding |
| Single-use aliquots | −20 °C or colder | Longer holding of solution | One thaw per tube; store in the dark |
| Working dilution in buffer or medium | As the assay requires | Immediate use | Prepare fresh; do not bank |
The wider framework, including freezer selection and desiccation, is in storing research peptides, and the reasoning behind solution time limits is in how long reconstituted peptides last.
Freeze–thaw cycles and aliquoting
Freezing a peptide solution is a stress, not a pause. As ice forms, the peptide and any salts are excluded into a shrinking liquid phase, so local concentration and ionic strength rise sharply, pH can drift, and the molecule meets a large ice–water interface. Bhatnagar, Bogner and Pikal separated these stresses in their analysis of freezing damage. A small, rigid cyclic peptide such as PT-141 has no tertiary fold to lose, which makes it more forgiving than a protein, but adsorption and aggregation losses still accumulate with each cycle.
Aliquoting is the answer. The concept is simple: decide how much solution one experiment consumes, divide the stock into that many portions in low-binding tubes immediately after reconstitution, freeze them together, and thaw one at a time. A thawed tube is mixed gently before use, because solutes stratify during freezing, and any remainder is discarded instead of refrozen. Frost-free freezers cycle their temperature to shed ice and are a poor home for peptide aliquots.
Light, moisture and surfaces
Light. Because the vial is clear glass and the molecule contains tryptophan, darkness is a storage condition in its own right. Keep the vial in its carton, wrap aliquot racks in foil or use amber tubes, and avoid leaving solutions beside a window or under a biosafety-cabinet lamp.
Moisture. Residual water is the main determinant of solid-state stability in a lyophilized product. The stopper and crimp do that job until they are breached; after that, the cake should be reconstituted, not returned to storage half-used. Weighing portions out of an opened vial is the commonest way moisture reaches the powder.
Adsorption. Peptides stick to glass and plastic, and the loss is proportionally greatest in dilute solutions. Goebel-Stengel and colleagues showed that recovery of peptides varies widely with tube material. For PT-141 the practical rules are to keep stock reasonably concentrated, make dilute working solutions immediately before use, prefer low-binding polypropylene, and keep tube type constant across an experimental series so that any loss is at least consistent.
Visual quality checks
A correctly reconstituted solution is clear, colorless and free of visible particles. Checks worth making every time the vial is handled:
- Clarity. Haze or opalescence suggests incomplete dissolution, aggregation or contamination. Allow a few more minutes at room temperature with gentle rolling before concluding anything.
- Particulates. Fibers, flecks or stopper fragments (coring) mean the solution should not go into an assay.
- Color. A yellow tint in a tryptophan-containing peptide is consistent with photo-oxidation and is grounds to retire the vial.
- Growth. Cloudiness that appears days after a clear start, especially in unpreserved water, points to microbial growth.
- Closure. A loose crimp, a heavily punctured stopper or liquid on the outside of the seal undermines everything else.
Visual inspection cannot confirm identity or purity; it only catches gross failures. Troubleshooting is covered in more depth in cloudy peptide vial after reconstitution.
Labels and records
A vial without a label is an unknown. At minimum the container should carry the compound name, lot number, concentration, diluent, preparation date and the preparer's initials. The notebook or inventory entry should add the date of receipt and the condition of the cake, the storage location and temperature, the certificate reference where one is published, the number of aliquots made, each withdrawal from a multi-entry vial, and any deviation such as a freezer alarm or a second thaw. Because PT-141 and Melanotan II differ by a single terminal group and look identical in the vial, unambiguous naming on every tube is a real safeguard, not a formality.
What not to do
| Practice to avoid | Why it causes trouble | Better approach |
|---|---|---|
| Opening a vial straight from the freezer | Condensation wets the cake | Equilibrate to room temperature first |
| Shaking or vortexing to speed dissolution | Foaming and interfacial aggregation | Swirl or roll and wait |
| Leaving the clear vial on the bench | Photo-oxidation of tryptophan | Keep boxed or foil-wrapped |
| Holding unpreserved solution in the refrigerator for weeks | No barrier to microbial growth | Aliquot and freeze, or use preserved diluent |
| Refreezing a thawed tube | Cumulative freeze–thaw loss | Single-use aliquots |
| Storing stock in assay buffer | Salt concentration and pH shifts on freezing | Store in water; dilute at time of use |
| Banking very dilute solutions | Adsorption removes a large fraction of the peptide | Dilute immediately before use in low-binding tubes |
| Abbreviated or missing labels | Confusion with the amide analog or with other lots | Full label at the moment of preparation |
What the stability literature does and does not establish
General principles are well documented. Reviews by Manning and colleagues and by Wang describe the chemical and physical routes by which peptides and proteins degrade in solution and in the dried state, and Kerwin and Remmele review photodegradation, with tryptophan prominent among the affected residues. Those principles, combined with the sequence, justify the precautions above.
What is not available in the open peer-reviewed literature is a compound-specific, time-resolved stability study of research-grade PT-141 reconstituted in bacteriostatic water and held in a laboratory refrigerator. No degradation rate, half-life in the vial or percentage loss per freeze–thaw cycle is quoted here, because any such figure would be invented. Time limits used for solutions are therefore conventions borrowed from general practice for preserved multi-use containers. A laboratory that needs to rely on an older solution should verify it analytically, for example by repeating an HPLC purity check against the starting material, instead of trusting a calendar.
Related PT-141 research
- PT-141 research overview: structure, receptor pharmacology and the preclinical literature
- PT-141 purity testing: what an HPLC result does and does not show
- Where to buy PT-141: sourcing criteria for research material
- PT-141 vs Melanotan II: the acid and amide analogs side by side
- Storing research peptides and how long reconstituted peptides last
Summary
PT-141 is among the more robust research peptides on paper: a lactam ring with no disulfide, norleucine with no oxidizable sulfur, and no deamidation-prone residues. Its vulnerabilities are the indole of tryptophan, the general hazards shared by every peptide solution (microbial growth, adsorption, repeated freezing) and simple misidentification against its amide analog. Store the sealed vial cold, dry and dark; reconstitute gently in the diluent that matches the intended use pattern; aliquot once; inspect every time; and write everything down. For laboratory research use only.
Frequently asked questions
What does lyophilized PT-141 look like?
A white to off-white cake or loose powder at the bottom of a sealed clear glass vial. Fragmented powder is normal after shipping. A collapsed, sticky or yellowed residue suggests moisture or heat exposure and should be noted in the receiving record.
Should PT-141 be reconstituted with bacteriostatic water or sterile water?
It depends on how the solution will be used. Bacteriostatic water contains a preservative and suits a vial that is entered repeatedly while stored at 2–8 °C. Sterile water has no additives and suits a stock that is split into single-use aliquots and frozen on the day it is made.
How should the unopened PT-141 vial be stored?
According to the product page, refrigerate at 2–8 °C and use −20 °C for long-term holding, protected from heat, moisture and light. Keeping the clear vial inside its box covers the light requirement.
How long does reconstituted PT-141 last?
No compound-specific stability study for research-grade PT-141 in bacteriostatic water has been published in the peer-reviewed literature. Laboratories apply the general convention of a few weeks at 2–8 °C for preserved multi-entry vials and freeze single-use aliquots for anything longer.
Does PT-141 contain methionine or cysteine?
No. Norleucine replaces methionine at the first position and the ring is closed by a lactam bond between aspartic acid and lysine side chains, so there is no methionine sulfoxide pathway and no disulfide chemistry to manage.
Why does PT-141 need protection from light?
The sequence contains one tryptophan, whose indole ring is a recognized site of photo-oxidation in peptides, and one histidine. The vial is clear glass, so light protection comes from the carton, foil or amber secondary containers.
Can PT-141 solution be frozen and thawed repeatedly?
It should not be. Each cycle exposes the peptide to concentration, pH and interface stresses and adds adsorption loss. Divide the stock into single-use aliquots after reconstitution and thaw each tube once.
How is PT-141 different from Melanotan II for handling purposes?
The two share the same lactam-bridged ring. PT-141 ends in a free carboxylic acid, whereas Melanotan II ends in an amide, so PT-141 carries about one fewer net positive charge at neutral pH. Storage and reconstitution practice is the same, but the compounds are distinct and must be labelled separately.
What does a properly reconstituted PT-141 solution look like?
Clear and colorless with no visible particles. Persistent haze, floating material, a yellow tint or cloudiness that develops during storage are reasons to withdraw the vial from use.
How is the concentration of a PT-141 stock worked out?
Concentration is the mass in the vial divided by the volume of diluent added. The reconstitution calculator at /calculator performs that arithmetic for any vial size and volume; for precise molar work, correct for net peptide content where it is reported on the certificate.
What should be recorded when a PT-141 vial is reconstituted?
Compound name, lot number, diluent, final concentration, date, preparer, storage location, number of aliquots and every later withdrawal or thaw. The certificate for the lot, where published, should be filed with the record.
References
- Al-Obeidi F, Castrucci AM, Hadley ME, Hruby VJ. Potent and prolonged-acting cyclic lactam analogs of α-melanotropin: design based on molecular dynamics. J Med Chem. 1989;32(12):2555-2561. doi:10.1021/jm00132a010
- Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006;27(4):921-930. doi:10.1016/j.peptides.2005.01.029
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. doi:10.1016/S0378-5173(00)00423-3
- Kerwin BA, Remmele RL Jr. Protect from light: photodegradation and protein biologics. J Pharm Sci. 2007;96(6):1468-1479. doi:10.1002/jps.20815
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
